Financial Performance - For the nine months ended September 30, 2020, the group's unaudited revenue was approximately SGD 17.1 million, an increase of approximately SGD 6.5 million or 61.3% compared to SGD 10.6 million for the same period in 2019[5]. - The group's unaudited profit for the nine months ended September 30, 2020, was approximately SGD 0.8 million, compared to a loss of approximately SGD 1.8 million for the same period in 2019[5]. - Basic and diluted earnings per share for the nine months ended September 30, 2020, were 0.16 Singapore cents, compared to a loss of 0.46 Singapore cents for the same period in 2019[5]. - The gross profit for the nine months ended September 30, 2020, was SGD 4.1 million, compared to SGD 0.7 million for the same period in 2019[9]. - Operating profit for the nine months ended September 30, 2020, was SGD 1.4 million, compared to an operating loss of SGD 1.6 million for the same period in 2019[9]. - The total comprehensive income for the nine months ended September 30, 2020, was SGD 0.8 million, compared to a total comprehensive loss of SGD 1.8 million for the same period in 2019[12]. - The company reported a profit attributable to equity holders of SGD 731,000 for the nine months, a turnaround from a loss of SGD 1,849,000 in the same period last year[38]. - The overall gross profit increased by approximately SGD 3.4 million or 485.7% to about SGD 4.1 million for the nine months ended September 30, 2020, with a gross profit margin rising from approximately 6.5% to about 24.0%[48]. Revenue Sources - Revenue for the nine months ended September 30, 2020, was SGD 17,140,000, an increase of 61.5% compared to SGD 10,639,000 for the same period in 2019[22]. - Sales of goods contributed SGD 16,652,000 to revenue, up from SGD 10,501,000, reflecting a growth of 58.5% year-over-year[22]. - The company recorded other income of SGD 0.87 million for the nine months ended September 30, 2020, compared to SGD 0.19 million for the same period in 2019[9]. - Other income increased to SGD 866,000 from SGD 188, marking a significant rise of 360.6%[23]. - The new business activities in China related to the development, manufacturing, and installation of gaming machines and equipment generated approximately SGD 2.3 million in revenue[46]. - The Chinese wine trading business began generating revenue starting from the third quarter of 2020[43]. Expenses and Costs - Cost of goods sold for the nine months was SGD 13,035,000, compared to SGD 9,950,000 in the previous year, representing a 31.1% increase[26]. - Total expenses for the nine months were SGD 16,623,000, up from SGD 12,386,000, indicating a 34.5% increase[26]. - The administrative expenses increased by approximately SGD 1.1 million or 50.0% to about SGD 3.3 million for the nine months ended September 30, 2020, primarily due to salaries and benefits related to new business activities in China[51]. - Research and development expenses increased to SGD 271,000 from SGD 113,000, reflecting a growth of 139.8%[26]. - The sales cost rose by approximately SGD 3.0 million or 30.0% to about SGD 13.0 million for the nine months ended September 30, 2020, consistent with the increase in revenue[47]. Dividends and Shareholder Information - The board of directors did not recommend the payment of dividends for the nine months ended September 30, 2020[6]. - The company did not recommend an interim dividend for the nine months ended September 30, 2020[39]. - As of September 30, 2020, the major shareholder, Tianyun Global Limited, owns 204,000,000 shares, representing 44.35% of the company's total shares[75]. - Ms. Shi Huiling holds 30,000,000 shares, accounting for 6.52% of the company's total shares[75]. Corporate Governance and Compliance - The company has adhered to the corporate governance code based on GEM listing rules, with compliance noted for the nine months ending September 30, 2020[90]. - The audit committee, consisting of three independent non-executive directors, has reviewed the unaudited financial data for the nine months ending September 30, 2020, ensuring compliance with applicable accounting standards and GEM listing rules[94]. - The company has confirmed that all directors have complied with the trading standards for securities transactions as per GEM listing rules for the nine months ending September 30, 2020[91]. Stock Options and Share Buybacks - The company has not granted any stock options as of September 30, 2020, under its stock option plan adopted on December 19, 2017[86]. - The stock option plan allows for a maximum of 10% of the issued shares to be granted, which equates to 40,000,000 shares[81]. - No stock options have been exercised or granted in the nine months ending September 30, 2020[86]. - No share buybacks or sales were conducted by the company or its subsidiaries in the nine months ending September 30, 2020[79]. Other Information - The company primarily engages in the manufacturing and sale of disposable medical device components and provides mold-making services in Singapore[15]. - The company adopted new accounting standards effective January 1, 2020, with no significant impact on its accounting policies[20]. - The financial costs for the nine months ended September 30, 2020, were SGD 0.23 million, slightly down from SGD 0.25 million for the same period in 2019[9]. - The financial costs remained stable at approximately SGD 0.2 million for both the nine months ended September 30, 2019, and 2020[52]. - The company has no knowledge of any other interests or short positions in its shares that require disclosure under the Securities and Futures Ordinance as of the report date[76]. - The company has no competition or conflicts of interest involving its directors or controlling shareholders as of the report date[87]. - The compliance advisor has no interests related to the company that require disclosure under GEM Listing Rules as of the report date[89].
官酝控股(08513) - 2020 Q3 - 季度财报